The meeting will focus on advances in diagnostic pathology with emphasis on translational discoveries and molecular approaches that have impacted the clinical care of patients with cancer. The program will be both practical and informative, geared towards practicing physicians and translational scientists. Lectures with emphasize state-of-the-art laboratory techniques that help inform targeted therapies, including next-generation sequencing, immunohistochemistry, and fluorescence in situ hybridization.